table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID 19 hospitalizedCOVID-19 mild to moderate
anti-inflammatory therapies
anti GM-CSF
mavrilimumab MASH-COVID ...
clarithromycine Rashad ...
colchicine GRECCO-19 Horby RECOVERY ... Salehzadeh COLCOVID COL-COVID ...
Colchicine plus rosuvastatin Gaitan-Duarte ...
non-steroidal anti-inflammatory drugs
Indomethacin Ravichandran
stem cells Lanzoni Carmenate ...

0 studies excluded by filtering options 0

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons